Vitamin D and multiple sclerosis: An update

Nutrition Reviews

Volumn 66, Issue SUPPL_2, 2008, Pages

  Cantorna, Margherita T ^a,b  

^a Center for Molecular Immunology and Infectious Disease   (United States)

^b PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

Hygiene hypothesis; Multiple sclerosis; Vitamin D

Indexed keywords

COLECALCIFEROL; VITAMIN D;

CENTRAL NERVOUS SYSTEM; CONFERENCE PAPER; ENVIRONMENTAL FACTOR; GEOGRAPHY; HEREDITY; HUMAN; IMMUNE SYSTEM; MULTIPLE SCLEROSIS; NONHUMAN; PHYSICIAN;

ANIMALIA;

EID: 52649158618     PISSN: 00296643     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1753-4887.2008.00097.x     Document Type: Conference Paper

References (19)

1. Ebers GC, Sadovnick AD. The role of genetic factors in multiple sclerosis susceptibility. J NeuroImmunol. 1994 54: 1 17.
2. Giovannoni G, Ebers G. Multiple sclerosis: the environment and causation. Curr Opin Neurol. 2007 20: 261 268.
3. Dean G. Annual incidence, prevalence, and mortality of multiple sclerosis in white South-African-born and in white immigrants to South Africa. Br Med J. 1967 2: 724 730.
4. Fleming JO, Cook TD. Multiple sclerosis and the hygiene hypothesis. Neurology. 2006 67: 2085 2086.
5. Ascherio A, Munger KL. Environmental risk factors for multiple sclerosis. Part I: the role of infection. Ann Neurol. 2007 61: 288 299.
6. Craelius W. Comparative epidemiology of multiple sclerosis and dental caries. J Epidemiol Community Health. 1978 32: 155 165.
7. Nieves J, Cosman F, Herbert J, Shen V, Lindsay R. High prevalence of vitamin D deficiency and reduced bone mass in multiple sclerosis. Neurology. 1994 44: 1687 1692.
8. Cantorna MT, Hayes CE, DeLuca HF. 1,25-Dihydroxyvitamin D3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis. Proc Natl Acad Sci USA. 1996 93: 7861 7864.
9. Munger KL, Zhang SM, O'Reilly E, et al. Vitamin D intake and incidence of multiple sclerosis. Neurology. 2004 62: 60 65.
10. Munger KL, Levin LI, Hollis BW, Howard NS, Ascherio A. Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA. 2006 296: 2832 2838.
11. Ozgocmen S, Bulut S, Ilhan N, Gulkesen A, Ardicoglu O, Ozkan Y. Vitamin D deficiency and reduced bone mineral density in multiple sclerosis: effect of ambulatory status and functional capacity. J Bone Miner Metab. 2005 23: 309 313.
12. van der Mei IA, Ponsonby AL, Dwyer T, et al. Vitamin D levels in people with multiple sclerosis and community controls in Tasmania, Australia. J Neurol. 2007 254: 581 590.
13. Mahon BD, Gordon SA, Cruz J, Cosman F, Cantorna MT. Cytokine profile in patients with multiple sclerosis following vitamin D supplementation. J NeuroImmunol. 2003 134: 128 132.
14. Nordvik I, Myhr KM, Nyland H, Bjerve KS. Effect of dietary advice and n-3 supplementation in newly diagnosed MS patients. Acta Neurol Scand. 2000 102: 143 149.
15. Goldberg P, Fleming MC, Picard EH. Multiple sclerosis: decreased relapse rate through dietary supplementation with calcium, magnesium and vitamin D. Med Hypotheses. 1986 21: 193 200.
16. Wingerchuk DM, Lesaux J, Rice GP, Kremenchutzky M, Ebers GC. A pilot study of oral calcitriol (1,25-dihydroxyvitamin D3) for relapsing-remitting multiple sclerosis. J Neurol Neurosurg Psychiatry. 2005 76: 1294 1296.
17. Eyles D, Almeras L, Benech P, et al. Developmental vitamin D deficiency alters the expression of genes encoding mitochondrial, cytoskeletal and synaptic proteins in the adult rat brain. J Steroid Biochem Mol Biol. 2007 103: 538 545.
18. Cantorna MT. Vitamin D and its role in immunology: multiple sclerosis, and inflammatory bowel disease. Prog Biophys Mol Biol. 2006 92: 60 64.
19. Cantorna MT, Mahon BD. Mounting evidence for vitamin D as an environmental factor affecting autoimmune disease prevalence. Exp Biol Med (Maywood). 2004 229: 1136 1142.